GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 149 filers reported holding GENMARK DIAGNOSTICS INC in Q4 2020. The put-call ratio across all filers is 2.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $150,000 | -77.0% | 10,300 | -86.2% | 0.00% | -100.0% |
| Q2 2016 | $651,000 | +65.2% | 74,800 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $394,000 | -32.1% | 74,800 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $580,000 | +9.0% | 74,800 | +10.7% | 0.00% | +33.3% |
| Q3 2015 | $532,000 | +2.5% | 67,600 | +18.0% | 0.00% | 0.0% |
| Q2 2015 | $519,000 | -30.2% | 57,300 | 0.0% | 0.00% | -25.0% |
| Q1 2015 | $744,000 | +9.7% | 57,300 | +15.1% | 0.00% | +33.3% |
| Q4 2014 | $678,000 | +56.2% | 49,800 | +2.9% | 0.00% | +50.0% |
| Q3 2014 | $434,000 | – | 48,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,365,000 | $16,186,000 | 1.49% |
| CADIAN CAPITAL MANAGEMENT, LP | 5,517,767 | $26,540,000 | 1.17% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 1,590,000 | $7,646,000 | 1.04% |
| Parkman Healthcare Partners LLC | 420,000 | $2,020,000 | 0.58% |
| Penn Capital Management Company, LLC | 977,526 | $4,702,000 | 0.49% |
| Bullseye Asset Management LLC | 79,272 | $381,000 | 0.37% |
| Bellevue Group AG | 2,441,241 | $11,742,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,783 | $1,447,000 | 0.18% |
| Granite Investment Partners, LLC | 589,313 | $2,835,000 | 0.13% |
| WRAPMANAGER INC | 68,163 | $328,000 | 0.10% |